Just before the holiday period, our community voted on the most impactful scientific papers of the year authored by industry and regulatory …
We recently had the pleasure of hosting the second Lhasa/IPEC Nitrites in Excipients Collaborative Meeting at our Head Office in Leeds. Following …
Curious to find out what we’ve been up to in 2025? This year, we have driven advancements in regulatory science, delivered innovation …
Insights on ICH Q3E, Extractables & Leachable (E&L) and risk assessment submissions Interpreting grey areas in the draft ICH Q3E guideline Earlier …
Following our recent Lhasa Limited hosted webinar, ICH S1B(R1): industry and regulatory best practice for confident carcinogenicity assessment, attendees had the rare …
Driving efficient early-stage ICH M7 classification through reliable mutagenic and carcinogenic data
In this latest blog, we will define the difference between certainty and uncertainty in the ICH M7 guideline for mutagenic impurities. Delving …